Noxa controls Mule-dependent Mcl-1 ubiquitination through the regulation of the Mcl-1/USP9X interaction

Biochemical and Biophysical Research Communications

Volumn 413, Issue 3, 2011, Pages 460-464

  Gomez Bougie, Patricia ^a,b,c   Ménoret, Emmanuelle ^a,b   Juin, Philippe ^a   Dousset, Christelle ^a,b   Pellat Deceunynck, Catherine ^a,b   Amiot, Martine ^a,b  

^a Service d'urologie Université et Hôpital de Nantes   (France)

^b Equipe 10 Labellisée Ligue Nationale Contre le Cancer 2008   (France)

^c NANTES UNIVERSITY HOSPITAL   (France)

Author keywords

E3 ligase; Mcl 1; Noxa; Ubiquitination; USP9X

Indexed keywords

MULE UBIQUITIN PROTEIN LIGASE E3; PROTEASOME; PROTEIN MCL 1; PROTEIN NOXA; UBIQUITIN; UBIQUITIN PROTEIN LIGASE; UBIQUITIN PROTEIN LIGASE E3; UNCLASSIFIED DRUG; USP9X DEUBIQUITINASE;

ARTICLE; HUMAN; HUMAN CELL; MITOCHONDRION; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN LOCALIZATION; PROTEIN METABOLISM; PROTEIN PROTEIN INTERACTION; UBIQUITINATION;

HEK293 CELLS; HUMANS; MITOCHONDRIA; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTO-ONCOGENE PROTEINS C-BCL-2; UBIQUITIN THIOLESTERASE; UBIQUITIN-PROTEIN LIGASES; UBIQUITINATION;

EID: 80053301716     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2011.08.118     Document Type: Article

References (27)

1. Rinkenberger J.L., Horning S., Klocke B., Roth K., Korsmeyer S.J. Mcl-1 deficiency results in peri-implantation embryonic lethality. Genes Dev. 2000, 14:23-27.
2. Opferman J.T., Iwasaki H., Ong C.C., Suh H., Mizuno S., Akashi K., Korsmeyer S.J. Obligate role of anti-apoptotic MCL-1 in the survival of hematopoietic stem cells. Science 2005, 307:1101-1104.
3. Opferman J.T., Letai A., Beard C., Sorcinelli M.D., Ong C.C., Korsmeyer S.J. Development and maintenance of B and T lymphocytes requires antiapoptotic MCL-1. Nature 2003, 426:671-676.
4. Nijhawan D., Fang M., Traer E., Zhong Q., Gao W., Du F., Wang X. Elimination of Mcl-1 is required for the initiation of apoptosis following ultraviolet irradiation. Genes Dev. 2003, 17:1475-1486.
5. Letai A. Growth factor withdrawal and apoptosis: the middle game. Mol. Cell 2006, 21:728-730.
6. Michels J., Johnson P.W., Packham G. Mcl-1 in focus. Int. J. Biochem. Cell Biol. 2005, 37:267-271.
7. Opferman J.T. Unraveling MCL-1 degradation. Cell Death Differ. 2006, 13:1260-1262.
8. Nencioni A., Hua F., Dillon C.P., Yokoo R., Scheiermann C., Cardone M.H., Barbieri E., Rocco I., Garuti A., Wesselborg S., Belka C., Brossart P., Patrone F., Ballestrero A. Evidence for a protective role of Mcl-1 in proteasome inhibitor-induced apoptosis. Blood 2005, 105:3255-3262.
9. Zhong Q., Gao W., Du F., Wang X. Mule/ARF-BP1a BH3-only E3 ubiquitin ligase catalyzes the polyubiquitination of Mcl-1 and regulates apoptosis. Cell 2005, 121:1085-1095.
10. Ding Q., He X., Hsu J.M., Xia W., Chen C.T., Li L.Y., Lee D.F., Liu J.C., Zhong Q., Wang X., Hung M.C. Degradation of Mcl-1 by beta-TrCP mediates glycogen synthase kinase 3-induced tumor suppression and chemosensitization. Mol. Cell. Biol. 2007, 27:4006-4017.
11. Inuzuka H., Shaik S., Onoyama I., Gao D., Tseng A., Maser R.S., Zhai B., Wan L., Gutierrez A., Lau A.W., Xiao Y., Christie A.L., Aster J., Settleman J., Gygi S.P., Kung A.L., Look T., Nakayama K.I., DePinho R.A., Wei W. SCF (FBW7) regulates cellular apoptosis by targeting MCL1 for ubiquitylation and destruction. Nature 2011, 471:104-109.
12. Wertz I.E., Kusam S., Lam C., Okamoto T., Sandoval W., Anderson D.J., Helgason E., Ernst J.A., Eby M., Liu J., Belmont L.D., Kaminker J.S., O'Rourke K.M., Pujara K., Kohli P.B., Johnson A.R., Chiu M.L., Lill J.R., Jackson P.K., Fairbrother W.J., Seshagiri S., Ludlam M.J., Leong K.G., Dueber E.C., Maecker H., Huang D.C., Dixit V.M. Sensitivity to antitubulin chemotherapeutics is regulated by MCL1 and FBW7. Nature 2011, 471:110-114.
13. Warr M.R., Acoca S., Liu Z., Germain M., Watson M., Blanchette M., Wing S.S., Shore G.C. BH3-ligand regulates access of MCL-1 to its E3 ligase. FEBS Lett. 2005, 579:5603-5608.
14. Reyes-Turcu F.E., Ventii K.H., Wilkinson K.D. Regulation and cellular roles of ubiquitin-specific deubiquitinating enzymes. Ann. Rev. Biochem. 2009, 78:363-397.
15. Schwickart M., Huang X., Lill J.R., Liu J., Ferrando R., French D.M., Maecker H., O'Rourke K., Bazan F., Eastham-Anderson J., Yue P., Dornan D., Huang D.C., Dixit V.M. Deubiquitinase USP9X stabilizes MCL1 and promotes tumour cell survival. Nature 2010, 463:103-107.
16. Willis S.N., Chen L., Dewson G., Wei A., Naik E., Fletcher J.I., Adams J.M., Huang D.C. Proapoptotic Bak is sequestered by Mcl-1 and Bcl-xL, but not Bcl-2, until displaced by BH3-only proteins. Genes Dev. 2005, 19:1294-1305.
17. Czabotar P.E., Lee E.F., van Delft M.F., Day C.L., Smith B.J., Huang D.C., Fairlie W.D., Hinds M.G., Colman P.M. Structural insights into the degradation of Mcl-1 induced by BH3 domains. Proc. Natl. Acad. Sci. 2007, 104:6217-6222.
18. Wuillème-Toumi S., Trichet V., Gomez-Bougie P., Gratas C., Bataille R., Amiot M. Reciprocal protection of Mcl-1 and Bim from ubiquitin-proteasome degradation. Biochem. Biophys. Res. Commun. 2007, 361:865-869.
19. Fujise K., Zhang D., Liu J., Yeh E.T. Regulation of apoptosis and cell cycle progression by MCL1. Differential role of proliferating cell nuclear antigen. J. Biol. Chem. 2000, 275:39458-39465.
20. Germain M., Duronio V. The N terminus of the anti-apoptotic BCL-2 homologue MCL-1 regulates its localization and function. J. Biol. Chem. 2007, 282:32233-32242.
21. Oda E., Ohki R., Murasawa H., Nemoto J., Shibue T., Yamashita T., Tokino T., Taniguchi T., Tanaka N. Noxa, a BH3-only member of the Bcl-2 family and candidate mediator of p53-induced apoptosis. Science 2000, 288:1053-1058.
22. Warr M.R., Mills J.R., Nguyen M., Lemaire-Ewing S., Baardsnes J., Sun K.L., Malina A., Young J.C., Jeyaraju D.V., O'Connor-McCourt M., Pellegrini L., Pelletier J., Shore G.C. Mitochondrion-dependent N-terminal processing of outer membrane Mcl-1 protein removes an essential Mule/Lasu1 protein-binding site. J. Biol. Chem. 2011, 286:25098-25107.
23. Nagai H., Noguchi T., Homma K., Katagiri K., Takeda K., Matsuzawa A., Ichijo H. Ubiquitin-like sequence in ASK1 plays critical roles in the recognition and stabilization by USP9X and oxidative stress-induced cell death. Mol. Cell 2009, 11:805-818.
24. Dupont S., Mamidi A., Cordenonsi M., Montagner M., Zacchigna L., Adorno M., Martello G., Stinchfield M.J., Soligo S., Morsut L., Inui M., Moro S., Modena N., Argenton F., Newfeld S.J., Piccolo S. FAM/USP9x, a deubiquitinating enzyme essential for TGFbeta signaling, controls Smad4 monoubiquitination. Cell 2009, 136:123-135.
25. Ventii K.H., Wilkinson K.D. Protein partners of deubiquitinating enzymes. Biochem. J. 2008, 414:161-175.
26. Gomez-Bougie P., Wuillème-Toumi S., Ménoret E., Trichet V., Robillard N., Philippe M., Bataille R., Amiot M. Noxa up-regulation and Mcl-1 cleavage are associated to apoptosis induction by bortezomib in multiple myeloma. Cancer Res. 2007, 67:18-24.
27. Fernández Y., Verhaegen M., Miller T.P., Rush J.L., Steiner P., Opipari A.W., Lowe S.W., Soengas M.S. Differential regulation of noxa in normal melanocytes and melanoma cells by proteasome inhibition: therapeutic implications. Cancer Res. 2005, 65:6294-6304.